Oppenheimer Asset Management Inc. boosted its holdings in shares of Prestige Consumer Healthcare Inc (NYSE:PBH) by 113.6% in the 3rd quarter, Holdings Channel reports. The fund owned 771 shares of the company’s stock after acquiring an additional 410 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Prestige Consumer Healthcare were worth $27,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also made changes to their positions in PBH. Bridger Capital Management LLC purchased a new stake in Prestige Consumer Healthcare during the 3rd quarter valued at about $52,000. Robeco Institutional Asset Management B.V. acquired a new stake in Prestige Consumer Healthcare during the 3rd quarter worth approximately $150,000. Hikari Power Ltd acquired a new stake in Prestige Consumer Healthcare during the 2nd quarter worth approximately $220,000. FDx Advisors Inc. purchased a new stake in shares of Prestige Consumer Healthcare in the 2nd quarter valued at approximately $245,000. Finally, Bank of Montreal Can increased its position in shares of Prestige Consumer Healthcare by 340.3% in the 2nd quarter. Bank of Montreal Can now owns 8,071 shares of the company’s stock valued at $256,000 after purchasing an additional 6,238 shares during the last quarter.
PBH stock opened at $37.96 on Friday. The company has a debt-to-equity ratio of 1.60, a current ratio of 2.08 and a quick ratio of 1.22. Prestige Consumer Healthcare Inc has a 1-year low of $26.25 and a 1-year high of $39.43. The firm has a fifty day moving average price of $35.72 and a two-hundred day moving average price of $32.69. The firm has a market cap of $1.90 billion, a price-to-earnings ratio of 13.65, a PEG ratio of 2.06 and a beta of 0.87.
A number of research analysts recently commented on PBH shares. DA Davidson increased their target price on shares of Prestige Consumer Healthcare from $31.00 to $32.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. TD Securities reduced their target price on shares of Prestige Consumer Healthcare from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Tuesday. CIBC reduced their price objective on shares of Prestige Consumer Healthcare from $94.00 to $81.00 in a research note on Tuesday. Royal Bank of Canada cut shares of Prestige Consumer Healthcare from an “outperform” rating to a “sector perform” rating and reduced their price objective for the company from $102.00 to $88.00 in a research note on Tuesday. Finally, ValuEngine upgraded shares of Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a report on Friday, July 26th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $64.06.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
See Also: What is a dividend reinvestment plan?
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.